How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice?

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 2, 2008, Pages

  Vanoirbeek, Jeroen A J ^a   De Vooght, Vanessa ^a   Vanhooren, Hadewijch M ^a   Nawrot, Tim S ^a   Nemery, Benoit ^a   Hoet, Peter H M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

dermal sensitization; IFN ; IL 4; lymphocyte subtypes; MIP 2; murine model; occupational asthma; TDI

Indexed keywords

CD19 ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 2; METHACHOLINE; TOLUENE DIISOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY FUNCTION; RESPONSE VARIABLE;

EID: 38949164437     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.09.006     Document Type: Article

References (32)

1. Butcher B.T., O'Neil C.E., Reed M.A., Salvaggio J.E., and Weill H. Development and loss of toluene diisocyanate reactivity: immunologic, pharmacologic, and provocative challenge studies. J Allergy Clin Immunol 70 (1982) 231-235
2. Lemiere C., Cartier A., Dolovich J., Chan-Yeung M., Grammer L., Ghezzo H., et al. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 154 (1996) 329-333
3. Lemiere C., Cartier A., Malo J.L., and Lehrer S.B. Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity. Am J Respir Crit Care Med 162 (2000) 976-980
4. Vandenplas O., and Malo J.L. Inhalation challenges with agents causing occupational asthma. Eur Respir J 10 (1997) 2612-2629
5. Gautrin D., and Lemiere C. Persistence of airway responsiveness to occupational agents: what does it matter?. Curr Opin Allergy Clin Immunol 2 (2002) 123-127
6. Park H.S., and Nahm D.H. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin Exp Allergy 27 (1997) 1145-1150
7. Rachiotis G., Savani R., Brant A., Macneill S.J., Newman T.A., and Cullinan P. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 62 (2007) 147-152
8. Lemiere C. Persistence of bronchial reactivity to occupational agents after removal from exposure and identification of associated factors. Ann Allergy Asthma Immunol 90 suppl 2 (2003) 52-55
9. Maghni K., Lemiere C., Ghezzo H., Yuquan W., and Malo J.L. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 169 (2004) 367-372
10. Mapp C.E., Boschetto P., Maestrelli P., and Fabbri L.M. Occupational asthma. Am J Respir Crit Care Med 172 (2005) 280-305
11. Malo J.L., Lemiere C., Gautrin D., and Labrecque M. Occupational asthma. Curr Opin Pulm Med 10 (2004) 57-61
12. Maestrelli P., Occari P., Turato G., Papiris S.A., Di Stefano A., Mapp C.E., et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy 27 (1997) 1292-1298
13. Herrick C.A., Xu L., Wisnewski A.V., Das J., Redlich C.A., and Bottomly K. A novel mouse model of diisocyanate-induced asthma showing allergic- type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 109 (2002) 873-878
14. Wisnewski A.V., Herrick C.A., Liu Q., Chen L., Bottomly K., and Redlich C.A. Human gamma/delta T-cell proliferation and IFN-gamma production induced by hexamethylene diisocyanate. J Allergy Clin Immunol 112 (2003) 538-546
15. Matheson J.M., Johnson V.J., and Luster M.I. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci 84 (2005) 99-109
16. Vanoirbeek J.A., Mandervelt C., Cunningham A.R., Hoet P.M.H., Xu H., Vanhooren H.M., et al. Validity of methods to predict the respiratory sensitizing potential of chemicals: a study with a piperidinyl chlorotriazine derivative that caused an outbreak of occupational asthma. Toxicol Sci 76 (2003) 338-346
17. Vanoirbeek J.A., Tarkowski M., Ceuppens J.L., Verbeken E.K., Nemery B., and Hoet P.H. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci 80 (2004) 310-321
18. Tarkowski M., Vanoirbeek J.A., Vanhooren H.M., De Vooght V., Mercier C.M., Ceuppens J., et al. Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol 292 (2007) L207-L214
19. Kimber I., Dearman R.J., Basketter D.A., Ryan C.A., and Gerberick G.F. The local lymph node assay: past, present and future. Contact Derm 47 (2002) 315-328
20. Dearman R.J., and Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J Appl Toxicol 21 (2001) 153-163
21. Pochanke V., Hatak S., Hengartner H., Zinkernagel R.M., and McCoy K.D. Induction of IgE and allergic-type responses in fur mite-infested mice. Eur J Immunol 36 (2006) 2434-2445
22. Arakawa H., Lotvall J., Kawikova I., Tee R., Hayes J., Lofdahl C.G., et al. Airway allergy to trimellitic anhydride in guinea pigs: different time courses of IgG1 titer and airway responses to allergen challenge. J Allergy Clin Immunol 92 (1993) 425-434
23. Zhang X.D., Murray D.K., Lewis D.M., and Siegel P.D. Dose-response and time course of specific IgE and IgG after single and repeated topical skin exposure to dry trimellitic anhydride powder in a Brown Norway rat model. Allergy 57 (2002) 620-626
24. Jones M.G., Floyd A., Nouri-Aria K.T., Jacobson M.R., Durham S.R., Taylor A.N., et al. Is occupational asthma to diisocyanates a non-IgE-mediated disease?. J Allergy Clin Immunol 117 (2006) 663-669
25. Park H.S., Kim H.Y., Nahm D.H., Son J.W., and Kim Y.Y. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate- human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J Allergy Clin Immunol 104 (1999) 847-851
26. Larsen S.T., and Nielsen G.D. The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. Toxicol Lett 170 (2007) 223-228
27. Sehra S., Pynaert G., Tournoy K., Haegeman A., Matthys P., Tagawa Y., et al. Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma. J Immunol 171 (2003) 2080-2089
28. Matheson J.M., Johnson V.J., Vallyathan V., and Luster M.I. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol Sci 84 (2005) 88-98
29. Vanoirbeek J.A., Tarkowski M., Vanhooren H.M., De Vooght V., Nemery B., and Hoet P.H. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol 117 (2006) 1090-1097
30. Zhang X.D., Fedan J.S., Lewis D.M., and Siegel P.D. Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J Allergy Clin Immunol 113 (2004) 320-326
31. Park H., Jung K., Kim H., Nahm D., and Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 29 (1999) 1395-1401
32. Pisati G., Baruffini A., Bernabeo F., Cerri S., and Mangili A. Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure. Int Arch Occup Environ Health 80 (2007) 298-305